Amanote Research
Register
Sign In
Gly82Ser Polymorphism of the Receptor for Advanced Glycation End Products Is Associated With an Increased Risk of Gastric Cancer in a Chinese Population
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-07-4808
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
June 1, 2008
Authors
H. Gu
L. Yang
Q. Sun
B. Zhou
N. Tang
R. Cong
Y. Zeng
B. Wang
Publisher
American Association for Cancer Research (AACR)
Related search
LINC00673 Rs11655237 Polymorphism Is Associated With Increased Risk of Cervical Cancer in a Chinese Population
Cancer Control
Medicine
Oncology
Hematology
The Receptor for Advanced Glycation End-Products Is a Central Mediator of Asthma Pathogenesis
A Prospective Study of Soluble Receptor for Advanced Glycation End-Products and Colorectal Cancer Risk in Postmenopausal Women
Cancer Epidemiology
Cancer Research
Epidemiology
Oncology
Association Between Serum Endogenous Secretory Receptor for Advanced Glycation End Products and Risk of Type 2 Diabetes Mellitus With Combined Depression in the Chinese Population
Diabetes Technology and Therapeutics
Medicine
Endocrinology
Medical Laboratory Technology
Metabolism
Diabetes
Reduced Soluble Receptor for Advanced Glycation End-Products in COPD
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Endogenous Secretory Receptor for Advanced Glycation End Products and Chronic Kidney Disease in the Elderly Population
American Journal of Nephrology
Nephrology
A Developmental Nephron Deficit in Rats Is Associated With Increased Susceptibility to a Secondary Renal Injury Due to Advanced Glycation End-Products
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Advanced Glycation End Products (AGEs) Promote Melanogenesis Through Receptor for AGEs
Scientific Reports
Multidisciplinary
S100A14 Rs11548103 G>A Polymorphism Is Associated With a Decreased Risk of Esophageal Cancer in a Chinese Population
Oncotarget
Oncology
